Australia markets open in 4 hours 51 minutes

InspireMD, Inc. (NSPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.5500-0.2200 (-7.94%)
As of 02:44PM EDT. Market open.

InspireMD, Inc.

4 Menorat Hamaor Street
Tel Aviv 6744832
Israel
972 3 6917691
https://www.inspiremd.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees68

Key executives

NameTitlePayExercisedYear born
Mr. Marvin L. SlosmanPresident, CEO & Director843.83kN/A1964
Mr. Craig ShoreCFO, Chief Administrative Officer, Secretary & Treasurer613.49kN/A1961
Mr. Shane Thomas GleasonChief Commercial Officer486.04kN/A1975
Mr. Andrea TommasoliChief Operating Officer359.27kN/A1972
Mr. Amir KohenVice President of Finance & Human ResourcesN/AN/AN/A
Dr. Patrick A. Verta DVM, M.D., MS StatExecutive Vice President of Clinical & Medical AffairsN/AN/A1958
Mr. Pete LigottiExecutive VP & GM of North AmericaN/AN/AN/A
Dr. Sol J. Barer Ph.D.Special Advisor to the Board13.92kN/A1947
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Corporate governance

InspireMD, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.